This article is more than 5 years old. Information may no longer be current.
Smith & Nephew posts second-quarter, half-year financials
Click Here to Manage Email Alerts
Smith & Nephew recently announced strong second-quarter trading and half-year financial results, according to a company press release.
Included in the company’s report was an underlying revenue increase of 5% in the second quarter and a 4% underlying revenue increase for the half-year. Trading profit in the half-year was also up by an underlying 6%, and the trading profit margin was up 70 basis points at 22.5% in that span.
The company also cited advanced wound care, emerging markets and knee implants as areas of substantial growth and performance throughout the second quarter.
“These strong results demonstrate the positive effects of our actions coming through across the group,” Olivier Bohuon, CEO of Smith & Nephew, said in the release. “Notably, in the second quarter, we continued the improvement in advanced wound care, achieved double-digit growth across the emerging markets, and delivered our best performance globally in reconstruction for 3 years, led by strong U.S. knee implants.”
The company reported an increase to 75% in its trading profit cash to conversion ratio within the half-year vs. 53% in the same period in 2014. The interim dividend was also up to 11.8 cents per share, from 11 cents in 2014, according to the release.
Reference: www.smith-nephew.com.